Cover Image

Novel 2,6,9-Trisubstituted Purines as Potent CDK Inhibitors Alleviating Trastuzumab-Resistance of HER2-Positive Breast Cancers

HER2-positive (HER2+) breast cancer is defined by <i>HER2</i> oncogene amplification on chromosome 17q12 and accounts for 15-20% population of breast-cancer patients. Therapeutic anti-HER2 antibody such as trastuzumab is used as the first-line therapy for HER2-positive breast cancers. Ho...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ratnakar Reddy Kuchukulla (Author), Injeoung Hwang (Author), Sang Won Park (Author), Sojeong Moon (Author), Suhn Hyung Kim (Author), Sumin Kim (Author), Hwan Won Chung (Author), Mi-Jung Ji (Author), Hyun-Mee Park (Author), Gu Kong (Author), Wooyoung Hur (Author)
Format:	Book
Published:	MDPI AG, 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs
by: Thalia Delgado, et al.
Published: (2024)

Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia
by: Jeanluc Bertrand, et al.
Published: (2022)

Phosphorylation of islet-1 serine 269 by CDK1 increases its transcriptional activity and promotes cell proliferation in gastric cancer
by: Qiong Shi, et al.
Published: (2021)

Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
by: Caitlin R. M. Oyagawa, et al.
Published: (2018)

Erratum: Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
by: Frontiers Production Office
Published: (2019)

Crystallography, in Silico Studies, and In Vitro Antifungal Studies of 2,4,5 Trisubstituted 1,2,3-Triazole Analogues
by: Katharigatta N. Venugopala, et al.
Published: (2020)

Synthesis and antitumor activity of certain 2,3,6-trisubstituted quinazolin-4(3H)-one derivatives
by: Safinaz E. Abbas, et al.
Published: (2013)

Development of newly synthesised quinazolinone-based CDK2 inhibitors with potent efficacy against melanoma
by: Eman R. Mohammed, et al.
Published: (2022)

Cost-effectiveness analysis of trastuzumab deruxtecan versus trastuzumab emtansine for HER2-positive breast cancer
by: Jiangping Yang, et al.
Published: (2022)

Design, synthesis and antitumor activity of 3,4,5-Trisubstituted Isoxazoles
by: Kanghui Duan, et al.
Published: (2024)

Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors
by: Lamya H. Al-Wahaibi, et al.
Published: (2022)

Interactions of 2,6-substituted purines with purine nucleoside phosphorylase from Helicobacter pylori in solution and in the crystal, and the effects of these compounds on cell cultures of this bacterium
by: Marta Narczyk, et al.
Published: (2022)

Therapeutic Response Monitoring with <sup>89</sup>Zr-DFO-Pertuzumab in HER2-Positive and Trastuzumab-Resistant Breast Cancer Models
by: Minwoo Kang, et al.
Published: (2022)

Effects of purine nucleotide administration on purine nucleotide metabolism in brains of heroin-dependent rats
by: Kun Li, et al.

The Mirror of Literature, Amusement, and Instruction. Volume 10, No. 269, August 18, 1827
by: Various

Purines in Pain as a Gliopathy
by: Giulia Magni, et al.
Published: (2021)

Purine Nucleotide Phosphorylase deficiency
by: Anirudh Mahajan, et al.
Published: (2024)

Purine Metabolism and Rett Syndrome
by: J Gordon Millichap
Published: (1996)

Effect of 1,4-naphthoquinone from Sisyrinchium palmifolium L. extract on in vivo Ki-67 expression and in silico CDK1, CDK2, CDK4 on colitis-associated colon cancer
by: Roihatul Muti'ah, et al.
Published: (2022)

Synthesis, carbonic anhydrase I and II inhibition studies of the 1,3,5-trisubstituted-pyrazolines
by: Halise Inci Gul, et al.
Published: (2017)

A Versatile Class of 1,4,4-Trisubstituted Piperidines Block Coronavirus Replication In Vitro
by: Sonia De Castro, et al.
Published: (2022)

Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazloidin-4-One Analogues: Insights into α-Glucosidase, α-Amylase, and Antioxidant Activities
by: Salma M. Khirallah, et al.
Published: (2022)

Adverse events during anti-TNF therapy in 269 patients with juvenile idiopathic arthritis
by: Tarkiainen M, et al.
Published: (2008)

Temporal changes in cyclinD-CDK4/CDK6 and cyclinE-CDK2 pathways: implications for the mechanism of deficient decidualization in an immune-based mouse model of unexplained recurrent spontaneous abortion
by: Zhuo Chang, et al.
Published: (2022)

Targeting purine metabolism in ovarian cancer
by: Jingchun Liu, et al.
Published: (2022)

Leishmania metacyclogenesis is promoted in the absence of purines.
by: Tiago Donatelli Serafim, et al.
Published: (2012)

Simulating Costs of Intravenous Biosimilar Trastuzumab vs. Subcutaneous Reference Trastuzumab in Adjuvant HER2-Positive Breast Cancer: A Belgian Case Study
by: Steven Simoens, et al.
Published: (2021)

Profiling and targeting HER2-positive breast cancer using trastuzumab emtansine
by: Sadeghi S, et al.
Published: (2014)

Lei no 13.269/2016: a comoção da sociedade vence o método científico!
by: Sandra Mara Campos Alves, et al.
Published: (2016)

Discovery of novel and potent CDK8 inhibitors for the treatment of acute myeloid leukaemia
by: Zhuoying Chen, et al.
Published: (2024)

Binding selectivity-dependent molecular mechanism of inhibitors towards CDK2 and CDK6 investigated by multiple short molecular dynamics and free energy landscapes
by: Lifei Wang, et al.
Published: (2023)

Recent Development of CDK2 Inhibitors as Anticancer Drugs: An Update (2015-2023)
by: Yumei Jin, et al.
Published: (2024)

Efficient Synthesis and Docking Analysis of Selective CDK9 Inhibitor NVP-2
by: Abdusaid Saidahmatov, et al.
Published: (2021)

Discovery of 3-((3-amino-1H-indazol-4-yl)ethynyl)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide (AKE-72), a potent Pan-BCR-ABL inhibitor including the T315I gatekeeper resistant mutant
by: Ashraf K. El-Damasy, et al.
Published: (2023)

Kinin and Purine Signaling Contributes to Neuroblastoma Metastasis
by: Henning Ulrich, et al.
Published: (2018)

Disorder of purine metabolism in the etiopathogenesis of urate nephrolithiasis
by: S. I. Vorotyntsev, et al.
Published: (2023)

Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression
by: Christina Vasalou, et al.
Published: (2024)

Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer
by: Hanzhi Liang, et al.
Published: (2022)

Multidimensional evaluation of teaching strategies for pharmacology based on a comprehensive analysis involving 21,269 students
by: Chen-Lin Xiao, et al.
Published: (2023)

Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab
by: Laure Thouvenin, et al.
Published: (2021)